Response to Rituximab-Based Therapy and Risk Factor Analysis in Epstein Barr Virus–Related Lymphoproliferative Disorder After Hematopoietic Stem Cell Transplant in Children and Adults: A Study From the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation-Reference-Cited by-同舟云学术

Response to Rituximab-Based Therapy and Risk Factor Analysis in Epstein Barr Virus–Related Lymphoproliferative Disorder After Hematopoietic Stem Cell Transplant in Children and Adults: A Study From the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation

Published:2013-06-13 Issue:6 Volume:57 Page:794-802
ISSN:1537-6591
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:

Author:

Styczynski Jan,Gil Lidia,Tridello Gloria,Ljungman Per,Donnelly J. Peter,van der Velden Walter,Omar Hamdy,Martino Rodrigo,Halkes Constantijn,Faraci Maura,Theunissen Koen,Kalwak Krzysztof,Hubacek Petr,Sica Simona,Nozzoli Chiara,Fagioli Franca,Matthes Susanne,Diaz Miguel A.,Migliavacca Maddalena,Balduzzi Adriana,Tomaszewska Agnieszka,Camara Rafael de la,van Biezen Anja,Hoek Jennifer,Iacobelli Simona,Einsele Hermann,Cesaro Simone

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/57/6/794/17853171/cit391.pdf

Reference34 articles.

1. Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study;Curtis;Blood,1999

2. Management of HSV, VZV and EBV infections in patients with hematological malignancies and after SCT: guidelines from the Second European Conference on Infections in Leukemia;Styczynski;Bone Marrow Transplant,2009

3. Use of rituximab and irradiated donor-derived lymphocytes to control Epstein-Barr virus–associated lymphoproliferation in patients undergoing related haplo-identical stem cell transplantation;McGuirk;Bone Marrow Transplant,1999

4. Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+ lymphomas after allogeneic hematopoietic cell transplantation;Doubrovina;Blood,2012

5. Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients;Heslop;Blood,2010

Cited by 197 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Post-transplant lymphoproliferative disorders after allogeneic hematopoietic stem cell transplantation: a case report, meta-analysis, and systematic review;Diagnostic Pathology;2024-09-07

2. Clinical manifestations and outcomes of EBV related secondary hemophagocytic lymphohistiocytosis;2024-08-26

3. EBV Reactivation and Disease in Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients and Its Impact on HSCT Outcomes;Viruses;2024-08-14

4. Cytokine-induced killer cells: new insights for therapy of hematologic malignancies;Stem Cell Research & Therapy;2024-08-13

5. Impact of prophylaxis with rituximab on EBV-related complications after allogeneic hematopoietic cell transplantation in children;Frontiers in Immunology;2024-07-11